Search Within

DigITs Research Group

Formats
  1. Meeting Abstract (264)
  2. Journal Article (219)
  3. Conference Paper (9)
  4. Editorial (9)
  5. Review (9)
  6. Research Letter (7)
  7. Book Section (3)
  8. Correspondence (1)
Groups
  1. Department of Medicine (383)
  2. Center for Hematologic Malignancies (290)
  3. Hematologic Malignancies, Division of (290)
  4. Survivorship Research (274)
  5. Bone Marrow Transplant (265)
  6. Epidemiology and Biostatistics (255)

More Groups

People
  1. Molly Maloy (269)
  2. Sergio Giralt (227)
  3. Miguel-Angel Perales (197)
  4. Sean Devlin (169)
  5. Ann Jakubowski (134)
  6. Esperanza Papadopoulos (108)

More People

Years
  1. 2025 (14)
  2. 2024 (24)
  3. 2023 (25)
  4. 2022 (37)
  5. 2021 (48)
  6. 2020 (68)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (126)
  2. Blood (62)
  3. Journal of Clinical Oncology (47)
  4. Bone Marrow Transplantation (31)
  5. Blood Advances (12)
  6. JCO Oncology Practice (11)

More Publications

Publishers
  1. Elsevier Inc. (155)
  2. American Society of Hematology (74)
  3. American Society of Clinical Oncology (67)
  4. Nature Publishing Group (50)
  5. Wiley Blackwell (18)
  6. Oxford University Press (13)

More Publishers

Results (521)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparable survival and incidence of toxicity for older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M. A.; Nieves, J.; Devlin, S.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Meeting Abstract

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V. E.; Hendrickson, R.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Blood (2016)

    Fulltext@MSK | Save
  • Multicolor flow cytometry and multi-gene next generation sequencing are complimentary and highly predictive for relapse in acute myeloid leukemia following allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Getta, B. M.; Devlin, S.; Maloy, M. A.; Mohanty, A.; Arcila, M.; Tallman, M. S.; Levine, R. L.; Giralt, S. A.; Roshal, M.
    Blood (2016)

    Fulltext@MSK | Save
  • MYC-dependent PI3K and MCL-1 feedbacks attenuate BET inhibitors activity in diffuse large B-cell lymphoma
    Meeting Abstract

    Derenzini, E.; Mondello, P.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Djaballah, H.; Ouerfelli, O.; de Stanchina, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Impact of genomic alterations on outcomes in myelofibrosis patients undergoing allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Rampal, R. K.; Tamari, R.; Zhang, N.; McNamara, C. J.; Rapaport, F.; Litvin, R.; Maloy, M. A.; Castro-Malaspina, H.; Giralt, S.; Weinberg, R. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A novel intermediate intensity conditioning regimen achieves high rates of long-term outpatient progression-free survival offsetting the disadvantage of early post-transplant complications in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Politikos, I.; Devlin, S.; Yoo, Y.; Mazis, C.; Maloy, M. A.; Scaradavou, A.; Dahi, P. B.; Perales, M.; Giralt, S.; Ponce, D. M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Prognostic factors of CLL patients undergoing reduced intensity allogeneic hematopoietic stem cell transplantation in the immunochemotherapy era
    Meeting Abstract

    Lahoud, O. B.; Hilden, P.; Maloy, M. A.; Dahi, P. B.; Castro-Malaspina, H.; Perales, M. A.; Giralt, S. A.; Sauter, C. S.
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation is underutilized in patients with myelodysplastic syndromes
    Meeting Abstract

    Getta, B.; Kishtagari, A.; Hilden, P.; Devlin, S.; Maloy, M. A.; Gonzales, P. K.; Shaffer, B. C.; Ponce, D. M.; Gyurkocza, B.; Barker, J. N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
    Meeting Abstract

    Cho, C.; Hilden, P.; Peled, J. U.; Avecilla, S. T.; Barba, P.; Barker, J. N.; Castro-Malaspina, H. R.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save